Pharmasaga participate in Berkeley SkyDeck Pitch Day

[Pharmasaga participate in Berkeley SkyDeck Pitch Day]

Pharmasaga was honored to participate in Berkeley SkyDeck Pitch Day and shared our latest progress in diabetes drug development with Silicon Valley investors, industry experts, and startup leaders.

We presented our first-in-class small-molecule therapy for diabetes, designed to reverse and ultimately cure diabetes through a novel mechanism of action.

The event provided valuable opportunities to connect with investors and potential partners as we continue advancing our global growth and fundraising efforts.